Insulin degludec and liraglutide Subcutaneous and Ranibizumab
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Ranibizumab Intraocular
- Insulin degludec and liraglutide Subcutaneous-Ranibizumab ophthalmic
- Insulin degludec and liraglutide Subcutaneous-Ranitidine
- Insulin degludec and liraglutide Subcutaneous-Ranitidine Capsule
- Insulin degludec and liraglutide Subcutaneous-Ranitidine Hydrochloride
- Insulin degludec and liraglutide Subcutaneous-Ranitidine Injection
- Ranibizumab-Insulin degludec Subcutaneous
- Ranibizumab-Insulin detemir
- Ranibizumab-Insulin Detemir (Cartridges and Prefilled Syringes)
- Ranibizumab-Insulin Detemir (Vials)
- Ranibizumab-Insulin detemir Subcutaneous
- Ranibizumab-Insulin glargine